Rising Star: Sullivan & Cromwell's Brad King
Brad King of Sullivan & Cromwell LLP has advised several high-figure deals surrounding innovative biotechnology and emerging health science applications, including guiding Seagen during an acquisition valued at more than $40 billion, earning...To view the full article, register now.
Already a subscriber? Click here to view full article